|
NEWS: VeinGogh instructed by FDA to cease marketing
On 18th April 2011, RefineUSA LLC, the makers of VeinGogh , were issued with a warning letter from the FDA instructing them to cease the promotion and marketing of VeinGogh WITH IMMEDIATE EFFECT. This will of course impact on their business but could also impact on those practices which have bought their device as they may be limited to what they are legally able to claim to their patients.
News: US Sales
We strongly recommend that you do not purchase devices through any third party purporting to be distributors. Unless purchased through us directly or via our network of approved sales representatives, we cannot ensure the authenticity of the devices nor will they be covered with aftercare support either in the US or from Europe. Should you be approached by any such third party, please report them to us immediately.
Please be aware that there is a copy product of our radiofrequency technology in the market. This copy product is not FDA approved and should not refer to clinical trials done and published with the TC3000/Veinwave product. On top, they claim to treat veins with a diameter larger than 1 millimeter with needles. Our ten years of clinical experience show this is not possible, therefore we developed the next generation of radiofrequency device called the EVRF. This is a new endoveneous treatment for veins between 1 and 5 millimeter.
F care systems
F care systems NV, established in Antwerp, Belgium is a leading manufacturer of medical and paramedical equipment. F care systems has developed products for the medical profession and for the esthetical medical market. F care systems works together with highly recognized doctors in their field of experience in order to improve the quality of its products and clearly outline the indications in which the products need to be applied.
Click here for the company website of F care systems.
|
